Remote Monitoring in Cancer Care: A Platform Study
This study investigates a device that closely monitors vital signs, as well as a smartphone application (app) that allows patients to respond to different questions and tests that will monitor for new symptoms. This study may help researchers understand if wearing the device is a better tool than standard vital sign assessment tools done only while at the doctor's office or hospital, and if using the smartphone app is a better tool than standard assessment tools used while in the doctor's office or hospital.
Checked against the public recordLast updated Oct 30, 2025 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Mayo Clinic
- Interventions being studied
- Other: Computer-Assisted Intervention; Procedure: Patient Monitoring; Other: Questionnaire Administration
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * ARM 1: Age \>= 18 years * ARM 1: Provide written informed consent * ARM 1: Patients undergoing commercial CAR-T cell therapy in an outpatient setting * ARM 2: Age \>= 18 years * ARM 2: Provide written informed consent * ARM 2: Patients with a plan to undergo radiation therapy for lung, gastrointestinal, or head and neck cancer Exclusion Criteria: * ARM 1: Non-English speaking * ARM 1: Planned initiation of lymphodepleting chemotherapy in the inpatient setting * ARM 2: Non-English speaking
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Mayo Clinic in RochesterRochester, Minnesota
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 30, 2025. Always confirm current availability with the study team.